Announcements Trials

Browse Landscape

Status

Completed 4 Terminated 1

Sponsor Class

Study Type

Interventional 8 Observational 1

Sponsor

Conditions

Metabolic Syndrome 1 Inflammation 1 Hypogonadism 1 Diabetes Mellitus 1

Interventions

Blood Specimen Collection 27 Surveys and Questionnaires 24 Magnetic Resonance Spectroscopy 10 Observation 7 Flow Cytometry 7 Specimen Handling 6 Amplified Fragment Length Polymorphism Analysis 6 exemestane 5 Radiotherapy 5 Magnetic Resonance Imaging 5 Immunoenzyme Techniques 5 Biopsy 5 Radiation 4 Neoadjuvant Therapy 4 Mental Status and Dementia Tests 4 Genetic Testing 4 Gene Expression Profiling 4 Electroporation 4 Data Collection 4 Bevacizumab 4 Trastuzumab 3 Tomography, X-Ray Computed 3 Tomography, Optical Coherence 3 Therapeutics 3 Surgical Procedures, Operative 3 Sunitinib 3 Sorafenib 3 Registries 3 Radiosurgery 3 Psychiatric Rehabilitation 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Observational × Pioglitazone × Clear all

NCT00743327 2012-08-06

ADT

National Institutes of Health Clinical Center (CC)

Diabetes Mellitus, Hypogonadism, Inflammation, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡